Juvenile Diabetes Research Foundation

Organisation

Trials

  • NCT06435156

    Collaborator, Phase 2, Recruiting, 320 people, 30 May 2024

  • NCT06147232

    Collaborator, Phase 2, Not yet recruiting, 69 people, 27 Nov 2023

  • dApagliflozin SC0062 and Prevention of Renal Injury; a Randomized Evaluation

    Collaborator, Phase 2, Not yet recruiting, 36 people, 10 Oct 2023

  • NCT05949281

    Collaborator, Phase 2, Active, not recruiting, 102 people, 18 Jul 2023

  • NCT05822609

    Collaborator, Phase 2, Recruiting, 60 people, 21 Apr 2023

  • NCT05742243

    Collaborator, Phase 2, Completed, 68 people, 23 Feb 2023

  • NCT05541484

    Collaborator, Phase 4, Completed, 21 people, 15 Sept 2022

  • NCT05537233

    Collaborator, Phase 2, Completed, 115 people, 13 Sept 2022

  • NCT04774224

    Collaborator, Phase 2, Completed, 91 people, 1 Mar 2021

  • NCT04661358

    Collaborator, Phase 3, Active, not recruiting, 563 people, 10 Dec 2020

  • NCT04545411

    Collaborator, Phase 1/2, Completed, 12 people, 11 Sept 2020

  • NCT04333823

    Collaborator, Phase 3, Active, not recruiting, 100 people, 3 Apr 2020

  • NCT03999853

    Collaborator, Phase 1/2, Completed, 6 people, 27 Jun 2019

  • NCT03899402

    Collaborator, Phase 2/3, Active, not recruiting, 78 people, 2 Apr 2019

  • NCT03704818

    Collaborator, Phase 1, Completed, 22 people, 15 Oct 2018

  • NCT03632759

    Collaborator, Early phase 1, Completed, 16 people, 15 Aug 2018

  • NCT02620553

    Collaborator, Phase 1/2, Completed, 25 people, 3 Dec 2015

  • NCT02490098

    Collaborator, Phase 2, Withdrawn, 0 people, 3 Jul 2015

  • NCT02383940

    Collaborator, Phase 2, Completed, 87 people, 10 Mar 2015

  • NCT02218619

    Collaborator, Phase 2, Completed, 20 people, 18 Aug 2014

Sources: clinicaltrials.gov

Funded papers

Sources: api.crossref.org

Named in competing interests

Sources: pubmed.ncbi.nlm.nih.gov

Papers